chr19-7918102-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001195259.2(TGFBR3L):c.929C>T(p.Pro310Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001195259.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBR3L | NM_001195259.2 | c.929C>T | p.Pro310Leu | missense_variant | 5/6 | ENST00000565886.2 | NP_001182188.1 | |
TGFBR3L | NM_001419781.1 | c.857C>T | p.Pro286Leu | missense_variant | 6/7 | NP_001406710.1 | ||
TGFBR3L | XM_011527610.3 | c.1108C>T | p.Pro370Ser | missense_variant | 3/4 | XP_011525912.1 | ||
TGFBR3L | XM_011527613.3 | c.1007C>T | p.Pro336Leu | missense_variant | 4/5 | XP_011525915.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBR3L | ENST00000565886.2 | c.929C>T | p.Pro310Leu | missense_variant | 5/6 | 5 | NM_001195259.2 | |||
TGFBR3L | ENST00000564348.5 | n.427C>T | non_coding_transcript_exon_variant | 4/5 | 5 | |||||
TGFBR3L | ENST00000566166.1 | n.278C>T | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 05, 2021 | The c.929C>T (p.P310L) alteration is located in exon 5 (coding exon 5) of the TGFBR3L gene. This alteration results from a C to T substitution at nucleotide position 929, causing the proline (P) at amino acid position 310 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.